Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022
March 03, 2022 08:03 ET
|
Codex DNA, Inc.
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced details for its first Investor R&D...
Codex DNA Showcases Potential of Groundbreaking SOLA Enzymatic DNA Synthesis Approach to Accelerate Development of Vaccines and Therapeutics
January 18, 2022 08:03 ET
|
Codex DNA, Inc.
Proprietary short oligo ligation assembly (SOLA) technology used to enzymatically synthesize DNA fragments for the construction of full-length H1 and N1 genes from influenza A virusInitial performance...